Skincure Oncology
Chicago, US · Founded 2016 · Delaware LLC · 1 known investors
Find your way into Skincure Oncology
76 people in our graph share verified history with the Skincure Oncology team — schools, employers, funds. One of them is your warm intro.
Dave Petersonunlockedknows KERWIN BRANDT · together at University of Northern Iowa (overlapped)
×2knows the team · via Benedictine University
×4knows the team · via University of Northern Iowa
×5knows the team · via BDO
SkinCure Oncology offers GentleCure/Image-Guided SRT, a superficial radiation therapy used as an alternative to Mohs surgery for treating non-melanoma skin cancer. Its technology is deployed at more than 325 dermatology practices across the United States.
Founders & leadership
KB
KERWIN BRANDTinChief Executive Officer, Manager and Co-FounderExecutive with over 30 years of healthcare leadership experience, including roles with multiple startups and involvement in healthcare financing transactions exceeding $300 million.
Investors · 1
Reported raises · per SEC filings
Form D private placements$33.5M disclosed across 4 rounds · 2016–2019
▶$30MraisedAug 2019 · 5 investors · OtherRule 506(b)
▶$30MraisedAug 2019 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kerwin BrandtExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jul 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$710KraisedApr 2019 · 9 investors · OtherRule 506(b)
▶$710KraisedApr 2019 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kerwin BrandtExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $710K
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$1.7MraisedMar 2018 · 13 investors · OtherRule 506(b)
▶$1.7MraisedMar 2018 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- KERWIN BRANDTExecutive Officer
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- Minimum investment
- $100K
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$1.1MraisedOct 2016 · 14 investors · OtherRule 506(b)
▶$1.1MraisedOct 2016 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- KERWIN BRANDTExecutive Officer
- Offering amount
- $4M
- Amount sold
- $1.1M
- Minimum investment
- $50K
- Sales commissions
- $25K
- Placement agents
- TRESTLE POINT, LLC
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Skincure Oncology for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Skincure Oncology do?
- SkinCure Oncology offers GentleCure/Image-Guided SRT, a superficial radiation therapy used as an alternative to Mohs surgery for treating non-melanoma skin cancer. Its technology is deployed at more than 325 dermatology practices across the United States.
- Who are Skincure Oncology's investors?
- Skincure Oncology's investors include H.I.G. Capital.
- How much funding has Skincure Oncology raised?
- Skincure Oncology has disclosed $33.5M raised across 4 rounds.
- Where is Skincure Oncology headquartered?
- Skincure Oncology is headquartered in Chicago, US.